Clovis Oncology, Inc. (CLVS - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.17 to $10.27 in the past one-month time frame.
The company has seen four positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Clovis. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Clovis currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Another stock worth considering in the Medical - Biomedical and Genetics industry is Anika Therapeutics Inc. (ANIK - Free Report) which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is CLVS going up? Or down? Predict to see what others think:Up or Down
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>